- Home
- GWH vs RLYB Comparison
GWH vs RLYB Comparison
Compare GWH & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWH
- RLYB
- Stock Information
- Founded
- GWH 2011
- RLYB 2018
- Country
- GWH United States
- RLYB United States
- Employees
- GWH N/A
- RLYB N/A
- Industry
- GWH Industrial Machinery/Components
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- GWH Miscellaneous
- RLYB Health Care
- Exchange
- GWH Nasdaq
- RLYB Nasdaq
- Market Cap
- GWH 25.3M
- RLYB 24.1M
- IPO Year
- GWH N/A
- RLYB 2021
- Fundamental
- Price
- GWH $1.40
- RLYB $0.59
- Analyst Decision
- GWH Hold
- RLYB Hold
- Analyst Count
- GWH 4
- RLYB 2
- Target Price
- GWH $2.67
- RLYB N/A
- AVG Volume (30 Days)
- GWH 129.8K
- RLYB 385.4K
- Earning Date
- GWH 11-12-2025
- RLYB 11-06-2025
- Dividend Yield
- GWH N/A
- RLYB N/A
- EPS Growth
- GWH N/A
- RLYB N/A
- EPS
- GWH N/A
- RLYB N/A
- Revenue
- GWH $6,166,000.00
- RLYB $761,000.00
- Revenue This Year
- GWH $139.06
- RLYB N/A
- Revenue Next Year
- GWH $70.81
- RLYB N/A
- P/E Ratio
- GWH N/A
- RLYB N/A
- Revenue Growth
- GWH N/A
- RLYB 154.51
- 52 Week Low
- GWH $0.76
- RLYB $0.22
- 52 Week High
- GWH $10.12
- RLYB $1.24
- Technical
- Relative Strength Index (RSI)
- GWH 42.71
- RLYB 55.28
- Support Level
- GWH $1.22
- RLYB $0.58
- Resistance Level
- GWH $1.50
- RLYB $0.61
- Average True Range (ATR)
- GWH 0.09
- RLYB 0.04
- MACD
- GWH 0.00
- RLYB -0.00
- Stochastic Oscillator
- GWH 47.37
- RLYB 73.86
About GWH ESS Tech Inc.
ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.